CLIENT RESULT
Diagnostics

Diagnostic Advisory Board

capabilities
Voice-of-Customer Research
KOL Identification
AdBoards
Project Details
capability
Voice-of-Customer Research
capability
KOL Identification
capability
AdBoards

Objective

A diagnostics company asked DeciBio to convene an advisory board (ad board) to help it position its relatively new somatic oncology genomic profiling product in an already competitive market
Key Metrics
8
Advisory Board Attendees
3
Hours of Live Discussion

Our Approach

DeciBio recruited and coordinated the scheduling for 8 oncology KOLs (both oncologists and pathologists) for a 3-hour virtual ad board. With input from the client, DeciBio prepared the questionnaire and stimuli for the attendees and facilitated the discussion.

Outcome

DeciBio delivered a recording and written summary of the ad board discussion. The summary included key takeaways related to:

  • Current use of genomic profiling assays in routine care
  • Factors that drive test differentiation
  • Evolution of current offering and potential future offerings
  • Tradeoffs and differentiating features of various evolutions
  • Competitor feedback and drivers of switching
  • Perceived value of potential new features and ancillary offerings
Project Details
Geographic Scope
U.S.
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch